Xeroderma Pigmentosum Group D Protein
"Xeroderma Pigmentosum Group D Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A DNA helicase that is a component of TRANSCRIPTION FACTOR TFIIH. It plays an essential role in NUCLEOTIDE EXCISION REPAIR, and mutations in this protein are associated with XERODERMA PIGMENTOSUM.
| Descriptor ID |
D051759
|
| MeSH Number(s) |
D08.811.277.040.025.159.500 D08.811.399.340.500 D12.776.260.775.875.875.500 D12.776.930.930.875.875.500
|
| Concept/Terms |
Xeroderma Pigmentosum Group D Protein- Xeroderma Pigmentosum Group D Protein
- Excision Repair Cross-Complementing Rodent Repair Deficiency, Group 2 Protein
- Excision Repair Cross Complementing Rodent Repair Deficiency, Group 2 Protein
- Xeroderma Pigmentosum Complementation Group D Protein
- ERCC2 Protein
|
Below are MeSH descriptors whose meaning is more general than "Xeroderma Pigmentosum Group D Protein".
Below are MeSH descriptors whose meaning is more specific than "Xeroderma Pigmentosum Group D Protein".
This graph shows the total number of publications written about "Xeroderma Pigmentosum Group D Protein" by people in this website by year, and whether "Xeroderma Pigmentosum Group D Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 3 | 3 |
| 2005 | 0 | 2 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Xeroderma Pigmentosum Group D Protein" by people in Profiles.
-
DNA Damage Response Alterations Predict for Neoadjuvant Chemotherapy Sensitivity in Muscle-Invasive Bladder Cancer: A Correlative Analysis of the SWOG S1314 Trial. JCO Precis Oncol. 2024 Nov; 8:e2400287.
-
Molecular architecture and functional dynamics of the pre-incision complex in nucleotide excision repair. Nat Commun. 2024 Oct 01; 15(1):8511.
-
Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 Trial. Eur Urol. 2024 Oct; 86(4):297-300.
-
Envisioning how the prototypic molecular machine TFIIH functions in transcription initiation and DNA repair. DNA Repair (Amst). 2020 12; 96:102972.
-
Exploratory analysis of ERCC2 DNA methylation in survival among pediatric medulloblastoma patients. Cancer Epidemiol. 2016 10; 44:161-166.
-
ERCC1 and ERCC2 variants predict survival in gastric cancer patients. PLoS One. 2013; 8(9):e71994.
-
Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx. Int J Cancer. 2013 Aug 01; 133(3):695-704.
-
Polymorphisms of nucleotide excision repair genes predict melanoma survival. J Invest Dermatol. 2013 Jul; 133(7):1813-21.
-
Sirt1 suppresses RNA synthesis after UV irradiation in combined xeroderma pigmentosum group D/Cockayne syndrome (XP-D/CS) cells. Proc Natl Acad Sci U S A. 2013 Jan 15; 110(3):E212-20.
-
A Turkish trichothiodystrophy patient with homozygous XPD mutation and genotype-phenotype relationship. J Dermatol. 2012 Dec; 39(12):1016-21.